Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.41 |
| ▸ | THPO | P40225 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30674028 | 0.80 | MAPT (0.67) | MAPTMAPK1HIF1AHSD17B10CYP1A2 | |
| SCHEMBL5285529 | 0.80 | MAPT (0.67) | MAPTMAPK1HIF1AHSD17B10CYP1A2 | |
| SCHEMBL1173905 | 0.80 | HTT (0.52) | MAPK1HIF1AHSD17B10TSHRNFKB1 | |
| Bromide SCHEMBL9444692 | 0.79 | MAPT (0.65) | MAPTMAPK1HIF1AHSD17B10CYP1A2 | |
| SCHEMBL31542040 | 0.78 | GSR (0.39) | MAPTHIF1AHSD17B10NFKB1ALOX15 | |
| SCHEMBL22249281 | 0.78 | MAPT (0.64) | MAPTMAPK1HIF1AHSD17B10CYP1A2 | |
| SCHEMBL24277508 | 0.76 | MAPT (0.46) | MAPTHIF1AHSD17B10TSHRHPGD | |
| Methoxymethane SCHEMBL20573056 | 0.74 | HTT (0.52) | MAPK1CYP1A2TSHRNFKB1HPGD | |
| SCHEMBL22249279 | 0.73 | ADRB2 (0.44) | MAPTMAPK1HIF1AHSD17B10CYP1A2 | |
| SCHEMBL31751559 | 0.73 | GABRA1 (0.44) | MAPTMAPK1HIF1AHSD17B10CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200230288-A1 | HYDROGEL USING, AS SUBSTRATE, HYALURONIC ACID DERIVATIVE MODIFIED WITH GALLOL GROUP AND USE THEREOF | AMTIXBIO CO., LTD. (KR) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200230288-A1 | HYDROGEL USING, AS SUBSTRATE, HYALURONIC ACID DERIVATIVE MODIFIED WITH GALLOL GROUP AND USE THEREOF | CD44, PGA5, HAO2 | MAPT 4300/4885MAPK1 2261/4885HIF1A 710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.